We are all made up of genes. They are the building blocks of what make us human, and scientists are discovering new functions of genes every day. Some genes determine hair color or eye color. Some even determine whether we can make that clover shape with our tongue (truly a miracle of nature). And some … Continued
Simply put, a biopsy is a surgical procedure that involves removing a piece of tissue, cell sample or fluid from part of the body, to determine if cancer cells are present. A biopsy is performed in a medical facility, and is often an out-patient procedure, meaning it does not require a hospital stay. Some biopsies, … Continued
(February 13, 2020) PARP inhibitors have shown to be a promising treatment option for a subset of ovarian cancer patients. As of February 2020, there are currently 3 FDA-approved PARP inhibitors for ovarian cancer: olaparib (Lynparza), niraparib (Zejula), and rucaparib (Rubraca). In an interview with OncLive, Dr. Robert Coleman, a member of OCRA’s Scientific Advisory … Continued
Recurrence is in the back of every ovarian cancer survivor’s mind. In this presentation, originally broadcast on November 28, 2016, Dr. Sarah Adams provided an overview of strategies for managing recurrent ovarian cancer, discussing the goals of treatment during recurrence, typical courses of treatment, and advice on how to approach making decisions about treatment during … Continued
Oliver Dorigo, MD, PhD, Director of the Stanford Gynecologic Oncology Clinical Care Program and Director of Stanford Obstetrics and Gynecology’s Division of Gynecologic Oncology provided an introduction to clinical trials for ovarian cancer patients. Dr. Dorigo discussed what clinical trials are, why they are important and how they work, the pros and cons of enrolling … Continued
Get email updates about research news, action alerts, and ways to join the fight.
